Initially, PTX3 was suggested to be useful only as a marker of lung carcinoma based on studies performed on lung cancer cell lines (Planque et al., 2009) but more recent studies have determined that PTX3 could be used as a serum biomarker for the diagnosis and prognosis of lung carcinoma. This evidence concerns the gene PTX3 and lung cancer.